Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches -  National Research Council,  Division on Earth and Life Studies,  Board on Life Sciences

Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches

Summary of a Workshop
Buch | Softcover
38 Seiten
2010
National Academies Press (Verlag)
978-0-309-15321-8 (ISBN)
22,40 inkl. MwSt
A major goal of the US Department of Defense (DOD) Transformational Medical Technologies Initiative (TMTI) is to develop countermeasures that will protect military personnel against bioweapons, including specific infectious-disease agents and toxins. An explicit TMTI objective is to respond quickly to such threats by producing an appropriate amount of an effective countermeasure—currently defined as enough material to treat or vaccinate 3 million personnel—within 12 months of identification of a specific threat. DOD officials call for TMTI programs to be up and running by 2014.



The National Academies hosted a workshop which brought together scientists from academe, government, and the biotechnology industry to identify and discuss challenges and ideas related to the TMTI's vision of developing countermeasures within a few months after an agent is identified. The workshop focused on manufacturing processes and specifically on the development of "manufacturing platforms"—repeatable components of manufacturing that reduce both development time and risk. An underlying assumption was that demonstrating that integrated platforms can reliably produce safe and efficacious countermeasures might shorten the regulatory approval process. The workshop is summarized in this book.

Table of Contents


Front Matter
INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS
Appendix A Statement of Task
Appendix B AGENDA
Appendix C Biographies

1 Front Matter; 2 INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS; 3 Appendix A Statement of Task; 4 Appendix B AGENDA; 5 Appendix C Biographies

Erscheint lt. Verlag 9.7.2010
Verlagsort Washington
Sprache englisch
Maße 216 x 279 mm
Themenwelt Studium Querschnittsbereiche Prävention / Gesundheitsförderung
ISBN-10 0-309-15321-2 / 0309153212
ISBN-13 978-0-309-15321-8 / 9780309153218
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
das Manual zur psychologischen Gesundheitsförderung

von Gert Kaluza

Buch | Hardcover (2023)
Springer Berlin (Verlag)
39,99
Wissenschaftlich basierte Empfehlungen, Tipps und Ernährungspläne für …

von Christoph Raschka; Stephanie Ruf

Buch (2022)
Thieme (Verlag)
51,00
Orthomolekulare Medizin in Prävention, Diagnostik und Therapie

von Volker Schmiedel

Buch | Hardcover (2022)
Thieme (Verlag)
71,00